logo
National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships

National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships

Business Wire3 days ago
DULUTH, Ga.--(BUSINESS WIRE)--National Vision, Inc., one of the nation's largest optical retailers providing quality, affordable eye care and eyewear, has awarded $7,000 in scholarships to three optometry students whose passion for community impact and commitment to vision equity stood out among this year's applicants for the National Optometric Student Association (NOSA) scholarship program.
This year's prompt challenged students to explore the link between vision health and success in school and the workplace, particularly in underserved communities where access to care remains limited. Submissions included essays and videos offering compelling personal perspectives, practical solutions and a shared belief in optometry's power to change lives.
'These students exemplify what it means to lead with both clinical skill and compassion,' said Alexander Smith, O.D., Head of Doctor Network at National Vision. 'Their ideas reflect the real-world challenges people face when vision care is out of reach, and the incredible potential optometrists have to bridge that gap.'
The 2025 National Vision NOSA Scholarship recipients are:
First Place ($4,000): Dominica Dzakah, Pennsylvania College of Optometry, Class of 2025
Second Place ($2,000): Antoinette Kanayo, University of Houston College of Optometry, Class of 2027
Third Place ($1,000): Monica Thu Do, UC Berkeley Herbert Wertheim School of Optometry & Vision Science, Class of 2027
The 2025 winners were awarded their scholarships at this year's National Optometric Association (NOA) Convention, held July 17 through July 20 in Columbus, Ohio, where their contributions were celebrated among peers and leaders in the field.
'This scholarship is about more than financial support—it's about investing in future doctors who are already stepping up to make a difference,' Smith added. 'We can't wait to see what these students accomplish next.'
Since launching the scholarship in 2015, National Vision has honored NOSA members who demonstrate academic excellence, community involvement and a dedication to serving minority and underserved populations. The program reinforces National Vision's mission to make quality eye care and eyewear more accessible while championing the next generation of leaders in optometry.
About National Vision Holdings, Inc.
National Vision Holdings, Inc. (NASDAQ: EYE) is one of the largest optical retail companies in the United States with over 1,200 stores in 38 states and Puerto Rico. With a mission of helping people by making quality eye care and eyewear more affordable and accessible, the company operates four retail brands: America's Best, Eyeglass World, and Vista Opticals inside select Fred Meyer stores and on select military bases, and an e-commerce website DiscountContacts.com, offering a variety of products and services for customers' eye care needs. For more information, please visit www.nationalvision.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

Yahoo

timean hour ago

  • Yahoo

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time). The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH executive team will be presenting. Event Details Date: Wednesday, August 6, 2025Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KSTLocation: Virtual (livestream access)Registration: Opens Monday, August 4 at Available after the event on the OSR Holdings Investor Relations website. Agenda Highlights Corporate overview and strategic vision Subsidiary and R&D pipeline updates: Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies Darnatein: DRT101 – a potent DMOAD candidate Woori IO acquisition: The opportunity for noninvasive CGM Equity Line of Credit (ELOC) financing strategy Blockchain & Tokenization strategy Live Q&A with management "This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth," said Peter Hwang, CEO of OSRH. "We look forward to showcasing the strength of our platform, the progress we've made, and the catalysts ahead. We are committed to transparency, disciplined execution, and delivering meaningful value to all stakeholders in the coming months."Featured Speakers: Mr. Peter Hwang – Chief Executive Officer Dr. Constance Höfer – Chief Scientific Officer Mr. Tim Smith – Global Investor Relations About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno‑oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting‑edge research and development. For more information, visit View original content to download multimedia: SOURCE OSR Holdings Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

TruBridge Announces Second Quarter 2025 Conference Call to Be Held Friday, August 8, 2025
TruBridge Announces Second Quarter 2025 Conference Call to Be Held Friday, August 8, 2025

Business Wire

time2 hours ago

  • Business Wire

TruBridge Announces Second Quarter 2025 Conference Call to Be Held Friday, August 8, 2025

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced that it will release its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. The Company will host a conference call at 7:30 a.m. Central Time, 8:30 a.m. Eastern Time on Friday, August 8, 2025. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A live broadcast of TruBridge's conference call will also be available online at the Company's investor relations website, The 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. About TruBridge TruBridge proudly supports rural and community hospitals and providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, we offer a mix of technology, services, and strategic expertise — including revenue cycle management, electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, personal care close to home. For more information, visit

BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates
BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates

Yahoo

time5 hours ago

  • Yahoo

BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates

BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.1 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +15.79%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.19, delivering a surprise of +137.5%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. BrightSpring Health Services, Inc., which belongs to the Zacks Medical Services industry, posted revenues of $3.15 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 5.40%. This compares to year-ago revenues of $2.73 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. BrightSpring Health Services, Inc. shares have added about 21.3% since the beginning of the year versus the S&P 500's gain of 7.8%. What's Next for BrightSpring Health Services, Inc.? While BrightSpring Health Services, Inc. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for BrightSpring Health Services, Inc. was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.28 on $3.16 billion in revenues for the coming quarter and $0.90 on $12.29 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Services is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, Progyny (PGNY), has yet to report results for the quarter ended June 2025. The results are expected to be released on August 7. This provider of fertility and family building benefits is expected to post quarterly earnings of $0.44 per share in its upcoming report, which represents a year-over-year change of +2.3%. The consensus EPS estimate for the quarter has been revised 4.1% lower over the last 30 days to the current level. Progyny's revenues are expected to be $322.5 million, up 6.1% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BrightSpring Health Services, Inc. (BTSG) : Free Stock Analysis Report Progyny, Inc. (PGNY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store